GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

Future of Swedish and Danish Life Science Event at Medicon Village, Lund, Sweden

30/3/2018

Global Regulatory Services (GRS) was present at the “Future of Swedish and Danish Life Science” event at the Lund (Sweden) based life science research park, Medicon Village, on 22 and 23 March 2018.

 

This year’s event focussed on “The latest in Precision Medicine and Big Data” and the fact that in the past 10 years personalised medicine, now often referred to as precision medicine, is seen as an attractive concept to many stakeholders in the life sciences industry.

 

Scandinavia has seen continued investment in the life sciences as well as displayed foresight in its initiatives. The Danish Government and Danish Regions have developed a National Strategy for Personalized Medicine 2017-2020. In Sweden, a new initiative for precision medicine – Genomic Medicine Sweden – aims to build a new type of infrastructure within Swedish Healthcare.

 

At Medicon Village, where GRS opened an office in 2017, the construction of a new purpose-built complex that will house 600 experts is progressing at pace and will be a significant contributor to this thriving life science ecosystem. On the Danish side, Copenhagen Science City has developed into an innovation district that gives access to a high concentration of education and research in the fields of medicine, health and natural science.

 

Following a welcome from Medicon Village, the main event on 22 March started with the sounding of the Nasdaq bell and was followed by presentations from life sciences clusters in Copenhagen, Lund and MedCity, who spoke about the expertise available within these clusters as well as the opportunities for greater collaboration. There was a Dragon’s Den style event which was won by a company based at Medicon Village and a series of presentations by innovative companies working with the life science sector and the genomic space. The main event concluded with a panel debate and the Nasdaq closing ceremony.

 

There were 1 to 1 partnering sessions available throughout the day, the opportunity for informal meetings as well as several exhibitors. There were further networking opportunities on 23 March with a speed networking event and the event concluded with a very informative tour of the SmiLe Incubator which houses several innovative, early stage companies.

 

GRS was able to meet many new, as well as an increasing number of familiar, faces and companies operating within the life sector in the Nordic region as it continues its successful entry into these regions. We aim to return to the next edition of the event in 2019 and continue our work for, and collaborations with, many dynamic Nordic life science companies.

 

Global Regulatory Services (GRS) is an award winning global consultancy offering Regulatory and Quality Compliance services to the Life Science Industry. The client base ranges from start-ups through to multi-nationals.  With a worldwide network of professionals GRS provides clients with ‘on the ground’, country-specific knowledge.  We have found it invaluable to have these local contacts in order to maximise the chance of a successful outcome in terms of a client’s regulatory strategy and/or licence submission.

 

Frequently operating at the forefront of technology GRS often deals with the more 'challenging' medical products and those which are considered to be 'borderline'. Today's advances in technology are phenomenal and, invariably, more products become 'borderline' as regulations are unable to keep up with the changes. 

 

At GRS, we love a challenge!  So please contact GRS so that we can have a chat about your specific regulatory compliance requirements.

Past Posts...

Stem Cells and Autism
18 September 2011